Recordati Industria Chimica e Farmaceutica S.p.A. (BIT: REC)
Italy
· Delayed Price · Currency is EUR
50.40
+0.05 (0.10%)
Dec 20, 2024, 5:35 PM CET
BIT: REC Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 557.41M EUR in the quarter ending September 30, 2024, with 8.89% growth. This brings the company's revenue in the last twelve months to 2.27B, up 11.68% year-over-year. In the year 2023, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.08B with 12.36% growth.
Revenue (ttm)
2.27B
Revenue Growth
+11.68%
P/S Ratio
4.58
Revenue / Employee
509.37K
Employees
4,455
Market Cap
10.31B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
Dec 31, 2019 | 1.48B | 129.61M | 9.59% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRecordati Industria Chimica e Farmaceutica News
- 25 days ago - Angelini Pharma Said to Discuss Combination With CVC’s Recordati - BNN Bloomberg
- 4 weeks ago - Recordati CEO sees 'substantial opportunity' in Sanofi drug purchase - CNBC
- 5 weeks ago - Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - GuruFocus
- 6 weeks ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Recordati reports nine-month results - Seeking Alpha
- 2 months ago - Sanofi Sells Global Rights To Rare Autoimmume Drug Enjaymo For $825M Upfront To Italian Firm Recordati - Benzinga
- 2 months ago - Recordati buys rights to rare immune disorder drug from Sanofi for $825mln - Zawya
- 5 months ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2024 Earnings Call Transcript - Seeking Alpha